Related Experiment Video
Updated: Jun 22, 2026

12:35
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)
Published on: March 17, 2012
[Gene diagnosis for spinal muscular atrophy and its application study]
Dong-hua Cao1, Mei-hong Ren, Chang-kun Lin
1Department of Medical Genetics, China Medical University, and The Second Affiliated Hospital, Shenyang, Liaoning, 110001 PR China.
Summary
This study establishes effective PCR-RFLP and multi-PCR-DHPLC testing systems for spinal muscular atrophy (SMA) gene diagnosis, carrier detection, and prenatal diagnosis, accurately identifying SMN1 gene deletions.
Area of Science:
- Molecular Genetics
- Genetic Diagnostics
Context:
- Spinal muscular atrophy (SMA) is a severe genetic disorder.
- Accurate diagnosis and carrier screening are crucial for genetic counseling and management.
Purpose:
- To develop and validate efficient molecular diagnostic methods for SMA.
- Establish a comprehensive testing system for gene diagnosis, carrier detection, and prenatal diagnosis of SMA.
Summary:
- PCR-RFLP and multi-PCR-DHPLC techniques were employed to detect SMN1 gene deletions.
- The study successfully diagnosed 25 out of 26 SMA patients and identified 52 carriers among parents.
- Prenatal diagnosis identified SMN1 gene deletions in 8 out of 20 fetuses.
Impact:
- The developed methods offer rapid and accurate diagnosis for SMA.
- These techniques facilitate effective carrier screening and prenatal diagnosis, aiding in reproductive decision-making for affected families.
More Related Videos
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

